[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337944-105":59,"doc-detail-337944-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","esf1-and-mipep-proteins-promote-estrogen-receptor-positive-breast-cancer-proliferation-and-are-associated-with-patient-prognosis","ESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosis","","Estrogen receptor-positive (ER+) breast cancer represents two-thirds of cases, yet early and late recurrences continue to threaten patients’ long-term survival and quality of life. Identifying candidate tumor antigens and actionable therapeutic targets is essential. Using iTRAQ proteomics, researchers compared ER+ breast cancer tissue with adjacent normal tissue, screened differential proteins, and validated results via IHC and western blot, followed by functional assays. Results highlight ESF1 and MIPEP as hub genes linked to poorer patient prognosis, with knockdown suppressing malignant cell behaviors.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/esf1-and-mipep-proteins-promote-estrogen-receptor-positive-breast-cancer-proliferation-and-are-associated-with-patient-prognosis/337944/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/esf1-and-mipep-proteins-promote-estrogen-receptor-positive-breast-cancer-proliferation-and-are-associated-with-patient-prognosis/337944.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What disease context motivated the study?","Question",{"text":112,"@type":113},"ER+ breast cancer accounts for about two-thirds of breast cancers, and both early and late recurrences threaten long-term survival and quality of life.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were ESF1 and MIPEP identified and validated?",{"text":117,"@type":113},"Isobaric tags for relative and absolute quantitation (iTRAQ) proteomics identified differential proteins, which were screened by bioinformatics and confirmed using immunohistochemical staining and western blot. STRING analysis indicated ESF1 and MIPEP as hub genes.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did knocking down ESF1 and MIPEP have?",{"text":121,"@type":113},"Knocking down ESF1 and MIPEP inhibited colony formation and increased cell apoptosis. ESF1 knockdown also inhibited wound healing, whereas MIPEP knockdown did not.",{"name":123,"@type":110,"acceptedAnswer":124},"How were ESF1 and MIPEP related to patient prognosis?",{"text":125,"@type":113},"ESF1 and MIPEP expression showed a negative association with patient prognosis, consistent with their role in promoting ER+ breast cancer proliferation.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},337944,1791213240,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Yu etal. Clinical Proteomics (2024) 21:50 Clinical Proteomics  \n[https://doi.org/10.1186/s12014-024-09502-8](https://doi.org/10.1186/s12014-024-09502-8)  \nRESEARCH Open Access  \nESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosis  \nQing Yu 1,2†, Chunhua Qu3†, Jinliang Liang4†, Peiqi Chen3, Kaiying Zhang3, Yanji Zhang3, Yuening Zhang5, Zherui Li6, Shaojun Liu7, Zhaoshou Yang8*, Hongyan Sun3* and Anli Yang3*  \nAbstract  \nBackground Estrogen receptor-positive (ER+) breast cancer accounts for two-thirds of all breast cancers, and its early and late recurrences still threaten patients’ long-term survival and quality of life. Finding candidate tumor antigensand potential therapeutic targets is critical to addressing these unmet needs.  \nMethod The isobaric tags for relative and absolute quantitation (iTRAQ) proteomic analysis was employed to identify the differential ly expressed proteins (DEPs) between ER + breast cancer and corresponding adjacent  \nnormal tissue. Candidate DEPs were screened by bioinformatic analyses, and their expression was confirmed by immunohistochemical (IHC) staining and western blot. A series of in vitro experiments, including wound healing assay, colony formation, and cell cycle assay, were performed to reveal the functions of selected DEPs. Additionally, their clinical significances were further analyzed.  \nResult A total of 369 DEPs (fold change ≥ 2.0 or ≤ 0. 66, P \u003C 0. 05) were discovered. Compared with normal tissue, 358 proteins were up-regulated and 11 proteins were down-regulated in ER + breast cancer. GO and KEGG enrichment analysis showed that DEPs were closely associated with RNA regulation and metabolic pathways. STRING analysis found ESF1 and MIPEP were the hub genes in breast cancer, whose increased expressions were verified by the IHC staining and western blot. Knocking down ESF1 and MIPEP inhibited colony formation and increased cell apoptosis. Besides, knocking down ESF1 inhibited wound healing but not MIPEP. In addition, ESF1 and MIPEP expression were negatively associated with patient prognosis.  \nConclusion The upregulation of ESF1 and MIPEP promoted ER + breast cancer proliferation, which might provide novel targets for the development of new therapies.  \n†Qing Yu, Chunhua Qu and Jinliang Liang contributed equally to this work.  \n*Correspondence: Zhaoshou Yang [yangzhsh3@gdpu.edu.cn](yangzhsh3@gdpu.edu.cn)[ ](yangzhsh3@gdpu.edu.cn)Hongyan Sun [sunhy@sysucc.org.cn](sunhy@sysucc.org.cn)[ ](sunhy@sysucc.org.cn)Anli Yang [yangal@sysucc.org.cn](yangal@sysucc.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nYu et al. Clinical Proteomics (2024) 21:50 Page 2 of 14  \nKeywords Estrogen receptor-positive breast cancer, ESF1, MIPEP, Prolifer","cbCais3U0RANN8gC","https://ap.wps.com/l/cbCais3U0RANN8gC","pdf",5764207,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What disease context motivated the study?\",\"answer\":\"ER+ breast cancer accounts for about two-thirds of breast cancers, and both early and late recurrences threaten long-term survival and quality of life.\"},{\"question\":\"How were ESF1 and MIPEP identified and validated?\",\"answer\":\"Isobaric tags for relative and absolute quantitation (iTRAQ) proteomics identified differential proteins, which were screened by bioinformatics and confirmed using immunohistochemical staining and western blot. STRING analysis indicated ESF1 and MIPEP as hub genes.\"},{\"question\":\"What effects did knocking down ESF1 and MIPEP have?\",\"answer\":\"Knocking down ESF1 and MIPEP inhibited colony formation and increased cell apoptosis. ESF1 knockdown also inhibited wound healing, whereas MIPEP knockdown did not.\"},{\"question\":\"How were ESF1 and MIPEP related to patient prognosis?\",\"answer\":\"ESF1 and MIPEP expression showed a negative association with patient prognosis, consistent with their role in promoting ER+ breast cancer proliferation.\"}]","ESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosis | PDF",1790021279,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69810e27f289b0a231b162f5d9a4aba3.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51da24ac69af6814f154362473b8063b.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/452570f6d2b97a332208ea186bd4e64f.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5d7f7b842e000fa81970c8789dbca48.webp",980,1306]